skip to Main Content

Mediware Products Protected From Heartbleed Bug

Analysis reveals that Mediware software is secure from the widespread security vulnerability

LENEXA, KS (April 28, 2014) – Mediware Information Systems, Inc. announced today that its products should not be impacted by the Heartbleed bug. This comes after conducting an extensive review. It is believed that up to two-thirds of companies on the Web have been affected by the vulnerability in the popular OpenSSL cryptographic software library.

Mediware’s review included both Mediware’s software products and the hosting environments that are used to deliver many of the Mediware products over the Web. “Our products do not generally use the technology that caused the problems, but to the extent we believed any of our products had any exposure, we acted to limit the risk within our continuous schedule of managed updates and patching,” stated Mediware director of product development, Scott Winchester.

Clients that are hosting Mediware solutions themselves will need to make sure that any third party software located on the same server is secure from the vulnerability., “Unfortunately, clients may still be at risk from the Heartbleed bug if an application susceptible to the Heartbleed bug is on the same server as the Mediware product,” Winchester warned. “This is a great example of why clients should consider having Mediware provide the hosting service. We have the manpower and expertise to safeguard our clients’ data.”

Clients are encouraged to reach out the Mediware support team with any questions or concerns.

About Mediware

Mediware was founded in 1970 and began offering software solutions in 1980 to help providers excel in high-growth, complex patient care environments that remain underserved by existing vendors. The company employs more than 400 subject matter experts who deeply understand business and care processes in highly specialized acute, non-acute and community-based care settings and have years of experience integrating systems. Mediware’s portfolio of solutions currently includes blood services, cellular therapy, medication management, physical rehabilitation, respiratory therapy, behavioral health and home care. For more information about Mediware products and services, visit

Back to top